Relapsed Glioblastoma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma (NCT01498328) | Celldex Therapeutics | 2011-12-01 |
Track Relapsed Glioblastoma automatically
Every clearance here is in the API, with alerts when new ones post.